Literature DB >> 21220713

Urinary albumin excretion is associated with nocturnal systolic blood pressure in resistant hypertensives.

Anna Oliveras1, Pedro Armario, Nieves Martell-Clarós, Luis M Ruilope, Alejandro de la Sierra.   

Abstract

Microalbuminuria is a known marker of subclinical organ damage. Its prevalence is higher in patients with resistant hypertension than in subjects with blood pressure at goal. On the other hand, some patients with apparently well-controlled hypertension still have microalbuminuria. The current study aimed to determine the relationship between microalbuminuria and both office and 24-hour ambulatory blood pressure. A cohort of 356 patients (mean age 64 ± 11 years; 40.2% females) with resistant hypertension (blood pressure ≥ 140 and/or 90 mm Hg despite treatment with ≥ 3 drugs, diuretic included) were selected from Spanish hypertension units. Patients with estimated glomerular filtration rate <30 mL/min/1.73 m(2) were excluded. All patients underwent clinical and demographic evaluation, complete laboratory analyses, and good technical-quality 24-hour ambulatory blood pressure monitoring. Urinary albumin/creatinine ratio was averaged from 3 first-morning void urine samples. Microalbuminuria (urinary albumin/creatinine ratio ≥ 2.5 mg/mmol in males or ≥ 3.5 mg/mmol in females) was detected in 46.6%, and impaired renal function (estimated glomerular filtration rate <60 mL/min/1.73 m(2)) was detected in 26.8%. Bivariate analyses showed significant associations of microalbuminuria with older age, reduced estimated glomerular filtration rate, increased nighttime systolic blood pressure, and elevated daytime, nighttime, and 24-hour diastolic blood pressure. In a logistic regression analysis, after age and sex adjustment, elevated nighttime systolic blood pressure (multivariate odds ratio, 1.014 [95% CI, 1.001 to 1.026]; P=0.029) and reduced estimated glomerular filtration rate (multivariate odds ratio, 2.79 [95% CI, 1.57 to 4.96]; P=0.0005) were independently associated with the presence of microalbuminuria. We conclude that microalbuminuria is better associated with increased nighttime systolic blood pressure than with any other office and 24-hour ambulatory blood pressure monitoring parameters.

Entities:  

Mesh:

Year:  2011        PMID: 21220713     DOI: 10.1161/HYPERTENSIONAHA.110.165563

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  15 in total

Review 1.  Non-interventional management of resistant hypertension.

Authors:  Michael Doumas; Costas Tsioufis; Charles Faselis; Antonios Lazaridis; Haris Grassos; Vasilios Papademetriou
Journal:  World J Cardiol       Date:  2014-10-26

Review 2.  Is nocturnal blood pressure reduction the secret to reducing the rate of progression of hypertensive chronic kidney disease?

Authors:  Rupal Mehta; Paul E Drawz
Journal:  Curr Hypertens Rep       Date:  2011-10       Impact factor: 5.369

3.  L/N-type calcium channel blocker cilnidipine reduces plasma aldosterone, albuminuria, and urinary liver-type fatty acid binding protein in patients with chronic kidney disease.

Authors:  Masanori Abe; Noriaki Maruyama; Hiroko Suzuki; Atsushi Inoshita; Yoshinori Yoshida; Kazuyoshi Okada; Masayoshi Soma
Journal:  Heart Vessels       Date:  2012-08-23       Impact factor: 2.037

Review 4.  Resistant hypertension: patient characteristics, risk factors, co-morbidities and outcomes.

Authors:  A Oliveras; A de la Sierra
Journal:  J Hum Hypertens       Date:  2013-08-29       Impact factor: 3.012

Review 5.  Cardiovascular and renal complications in patients with resistant hypertension.

Authors:  Elizabeth S Muxfeldt; Fabio de Souza; Victor S Margallo; Gil F Salles
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

6.  Nocturnal Hypertension Correlates Better With Target Organ Damage in Patients With Chronic Kidney Disease than a Nondipping Pattern.

Authors:  Cheng Wang; Wen-Jie Deng; Wen-Yu Gong; Jun Zhang; Qun-Zi Zhang; Zeng Chun Ye; Tanqi Lou
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-06-04       Impact factor: 3.738

7.  Proteinuria and nocturnal blood pressure dipping in hypertensive children and adolescents.

Authors:  Christine Y Bakhoum; Kim T Vuong; Caitlin E Carter; Francis B Gabbai; Joachim H Ix; Pranav S Garimella
Journal:  Pediatr Res       Date:  2021-01-27       Impact factor: 3.756

8.  Albuminuria, renal dysfunction and circadian blood pressure rhythm in older men: a population-based longitudinal cohort study.

Authors:  Hong Xu; Xiaoyan Huang; Ulf Risérus; Tommy Cederholm; Per Sjögren; Bengt Lindholm; Johan Ärnlöv; Juan Jesús Carrero
Journal:  Clin Kidney J       Date:  2015-08-04

Review 9.  Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines!

Authors:  Giuseppe Maiolino; Matteo Azzolini; Gian Paolo Rossi
Journal:  Front Cardiovasc Med       Date:  2015-02-04

10.  Sphingomyelin levels in nondipper and dipper hypertensive patients.

Authors:  Huan Zheng; Xiaoyun Xie; Nanzi Xie; Huifeng Xu; Junling Huang; Ming Luo
Journal:  Exp Ther Med       Date:  2013-12-19       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.